Related Experiment Video

Updated: Oct 9, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
10:19

A Murine Model of Group B Streptococcus Vaginal Colonization

Published on: November 16, 2016

Early-onset neonatal group B streptococcal sepsis: intrapartum antibiotic prophylaxis in the clinical setting

C T Gervasio1, B S Mantaring, S Alankar

  • 1Department of Pediatrics, Wayne State University, Detroit, MI, USA.

Journal of Perinatology : Official Journal of the California Perinatal Association
|March 28, 2001
PubMed

Insights

Intrapartum antibiotics effectively prevent early-onset Group B streptococcus (GBS) infection in newborns. However, clinical application of GBS prevention guidelines requires improvement for optimal outcomes.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Infectious Disease Prevention

Background:

  • Group B streptococcus (GBS) is a leading cause of early-onset neonatal infection.
  • Guidelines recommend intrapartum antibiotics for GBS-colonized pregnant women to prevent neonatal transmission.
  • Effective implementation of these guidelines in clinical settings is crucial.

Purpose of the Study:

  • To assess the clinical utilization of guidelines for intrapartum antibiotic prophylaxis in preventing early-onset GBS infection.
  • To identify challenges in the practical application of GBS prevention strategies.

Main Methods:

  • Retrospective review of maternal and infant medical records from 1993.
  • Analysis of antibiotic administration rates among GBS-colonized women.
  • Comparison of GBS infection rates between infants born to GBS-colonized mothers who received antibiotics and those who did not.

Main Results:

  • 77.8% of 443 GBS-colonized women received intrapartum antibiotics.
  • Four infants born to GBS-colonized mothers who received antibiotics developed GBS infection.
  • Infants born to GBS-colonized mothers who did not receive antibiotics had a significantly higher risk of GBS infection (OR 9.0, 95% CI 2.8-29.1).

Conclusions:

  • Intrapartum antibiotic prophylaxis is a vital strategy for preventing early-onset neonatal GBS infections.
  • Clinical application of GBS prevention guidelines presents challenges that need to be addressed.
  • Further optimization of guideline implementation is necessary to maximize the benefits of antibiotic prophylaxis.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...